TrialEuropean journal of clinical pharmacology2013

Single ascending oral dose pharmacokinetics and pharmacodynamics study of EV-077: the specific inhibitor of prostanoid- and isoprostane-induced cellular activation.

A Richardson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.